• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Vanda Tackles Wegovy-Driven Vomiting, Sparking Race To Ph. 3

    FIERCE BIOTECH

    Vanda`s Tradipitant Effective in Preventing GLP-1-Induced Nausea

    PR NEWSWIRE

    Vanda Pharma Reveals Q3 2025 Financials Result

    PR NEWSWIRE

    Vanda Pharmaceuticals Announces Collaborative Framework

    PR NEWSWIRE

    Vanda Pharma Accepts FDA for Hearing on NDA for Tradipitant

    PR NEWSWIRE

    Vanda Reports Positive Phase 3 Results For Tradipitant In Motion Sickness

    PR NEWSWIRE

    Vanda Pharmaceuticals announces the publication of an article on "The Efficacy of Tradipitant in Patients with Diabetic and Idiopathic Gastroparesis in Phase III Randomized Placebo-Controlled Clinical Trial" in the Clinical Gastroenterology and Hepatology Journal

    PR NEWSWIRE

    Vanda Announces that FDA Accepts NDA for Tradipitant for Gastroparesis

    PR NEWSWIRE

    Vanda’s tradipitant shows improvement in Covid-19 patients

    CLINICALTRIALSARENA

    FDA grants authorization for Individual Patient Expanded Access Protocol

    PRNEWSWIRE

    Vanda Announces the Initiation of ODYSSEY,FDA Approved Study of Tradipitant

    PRNEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.